% Expired Patents = 60.0

CIPO Patents = 2

EPO Patents = 1

Trademarks = 1

Forward Citations = 77

Loading Chart...

8 inventors (with patents filed for the assignee):

Gosse B Bruinsma (2 out of 2 patents)

Nigel H Greig (1 out of 27 patents)

Joerg Bruening (1 out of 7 patents)

4. Qian-Sheng Yu (1 out of 11 patents)

5. Arnold Brossi (1 out of 25 patents)

6. Timothy T Soncrant (1 out of 6 patents)

7. Claudio Soto-Jara (1 out of 3 patents)

8. Marvin Hausman (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 7994210 - Method of treating Down Syndrome (2011-08-09),

2. 7625942 - Method of treating Down syndrome (2009-12-01),

3. 6689753 - &bgr; sheet breaker peptide analogs that inhibit &bgr; pleated sheet formation in amyloid &bgr;-peptide (2004-02-10),

4. 6683105 - Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias (2004-01-27),

5. 6495700 - Process for producing phenserine and its analog (2002-12-17),

Company Overview

Axonyx, Inc. is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases. With a strong R&D team and strategic partnerships, Axonyx is at the forefront of research in the field. Their goal is to improve the lives of patients by providing groundbreaking therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#1,192 in New York, NY

#3,131 in New York

#51,620 in US

New York, NY, United States of America

Axonyx, Inc.

Forward Citations = 77

8 inventors:

Gosse B Bruinsma (2 out of 2 patents)

Nigel H Greig (1 out of 27 patents)

Joerg Bruening (1 out of 7 patents)

4. Qian-Sheng Yu (1 out of 11 patents)

5. Arnold Brossi (1 out of 25 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Axonyx, Inc.. Retrieved from https://idiyas.com/company/axonyx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]